Author:
Naito Sei,Makhov Peter,Astsaturov Igor,Golovine Konstantin,Tulin Alexei,Kutikov Alexander,Uzzo Robert G,Kolenko Vladimir M
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Adam RM, Mukhopadhyay NK, Kim J, Di Vizio D, Cinar B, Boucher K, Solomon KR, Freeman MR (2007) Cholesterol sensitivity of endogenous and myristoylated Akt. Cancer Res 67 (13): 6238–6246.
2. Adelaiye R, Ciamporcero E, Miles KM, Sotomayor P, Bard J, Tsompana M, Conroy D, Shen L, Ramakrishnan S, Ku SY, Orillion A, Prey J, Fetterly G, Buck M, Chintala S, Bjarnason GA, Pili R (2015) Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications. Mol Cancer Ther 14 (2): 513–522.
3. Buczek M, Escudier B, Bartnik E, Szczylik C, Czarnecka A (2014) Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: from the patient’s bed to molecular mechanisms. Biochim Biophys Acta 1845 (1): 31–41.
4. Canter D, Kutikov A, Golovine K, Makhov P, Simhan J, Uzzo RG, Kolenko VM (2011) Are all multi-targeted tyrosine kinase inhibitors created equal? An in vitro study of sunitinib and pazopanib in renal cell carcinoma cell lines. Can J Urol 18 (4): 5819–5825.
5. El Roz A, Bard JM, Huvelin JM, Nazih H (2013) The anti-proliferative and pro-apoptotic effects of the trans9, trans11 conjugated linoleic acid isomer on MCF-7 breast cancer cells are associated with LXR activation. Prostaglandins Leukot Essent Fatty Acids 88 (4): 265–272.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献